C-Rad AB (publ) (STO: CRAD.B)
Sweden
· Delayed Price · Currency is SEK
39.30
+0.05 (0.13%)
Oct 3, 2024, 5:29 PM CET
C-Rad AB Revenue
C-Rad AB had revenue of 129.40M SEK in the quarter ending June 30, 2024, with 42.83% growth. This brings the company's revenue in the last twelve months to 497.02M, up 39.09% year-over-year. In the year 2023, C-Rad AB had annual revenue of 424.62M with 40.92% growth.
Revenue (ttm)
497.02M
Revenue Growth
+39.09%
P/S Ratio
2.63
Revenue / Employee
5.29M
Employees
87
Market Cap
1.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 424.62M | 123.29M | 40.92% |
Dec 31, 2022 | 301.33M | 40.17M | 15.38% |
Dec 31, 2021 | 261.15M | 39.52M | 17.83% |
Dec 31, 2020 | 221.63M | 16.23M | 7.90% |
Dec 31, 2019 | 205.39M | 15.28M | 8.04% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.17B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |